Of note, in the SURPASS-4 trial, adjudicated major adverse cardiovascular events (MACE) were not increased with tirzepatide compared with insulin glargine over an extended follow-up period of 52 additional weeks after the main trial period of 52 weeks [21]
So, when it was time to try a GLP-1, he already had the process down
Use regional differences when negotiating: present competitor package prices as benchmarks, or ask multi-site clinics if they can match lower rates from another location
You may find yourself naturally leaving a few bites on your plate or skipping a late-night snack without much conscious effort
Compounded semaglutide is $129/month ($1,548/year)
For people trying to start or continue taking GLP-1 RA medication, access issues are incredibly distressing, especially because GLP-1 RAs are meant to be taken regularly and long-term